Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Early Initiation of Prophylactic Anticoagulation Reduces COVID-19 Mortality in Patients Admitted to the Hospital
- Safety and Efficacy of an rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine
- J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
- New COVID-19 Variants May Weaken Efficacy of Vaccines
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer–BioNTech COVID-19 Vaccine
- 2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots
- SGLT2 Inhibitors and GLP-1 Receptor Agonists for T2D
- Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults
- Association of Cumulative Systolic BP With Long-Term Risk of CVD and Healthy Longevity
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine